Skip to main content

Table 1 Characteristics of screened patients

From: Anticoagulant treatment in German family practices – screening results from a cluster randomized controlled trial

Patient characteristics

n = 1,761 (%)

Mean age years (SD)

74.6 (10.4)

Sex

 

Male

928 (52.7%)

Female

833 (47.3%)

Long-term indication for oral anticoagulation therapy

 

Atrial fibrillation/flutter

1,415 (80.4%)

Recurrent venous thromboembolism

142 (8.1%)

Recurrent pulmonary embolism

37 (2.1%)

Mechanical heart prosthesis

93 (5.3%)

Intracardiac thrombus

10 (0.6%)

Other indication

22 (1.2%)

No long-term indication

42 (2.4)

Antithrombotic medication*

 

Coumarin

1,554 (88.2%)

Dabigatran

46 (2.6%)

Rivaroxaban

61 (3.5%)

Antiplatelet therapy

55 (3.1%)

Other antithrombotic medication

11 (0.6%)

No antithrombotic medication

34 (2%)

Within therapeutic INR target range**

1,013 (67.3%)

Patient self-management

 

INR self-measuring and dose adjustment

149 (8.5%)

INR self-testing and dose adjustment by GP

1 (0.1%)

Patients with migration background

160 (9.1%)

Patients compliance assessed by GP

 

Very good compliance

1,157 (65.7%)

Good compliance

450 (25.6%)

Non-compliant

129 (7.3%)

No assessment available

25 (1.4%)

  1. *Apixaban had not been approved at the time of screening.
  2. **INR measurements available for 1,504 patients (89% of patients from category 1 (appropriate OAC treatment) and 3 (over-treatment with oral anticoagulants)).